Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Omar Abu-Fares"'
Autor:
Nunzio Davide de Manna, Florian Helms, Ezin Deniz, Till Frederik Kaireit, Omar Abu-Fares, Bastian Schmack, Arjang Ruhparwar, Alexander Weymann, Aron Frederik Popov
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 11 (2024)
BackgroundAcute Type A aortic dissection (ATAAD) with supra-aortic branch (SAB) malperfusion remains a formidable clinical challenge, often resulting in high mortality and complex treatment dilemmas. The introduction of the AMDS represents a signific
Externí odkaz:
https://doaj.org/article/36a2bed7063445298a6226bd7cdef4dd
Autor:
Johanna Ernst, Kai F. Storch, Anh Thu Tran, Maria M. Gabriel, Andrei Leotescu, Anna-Lena Boeck, Meret K. Huber, Omar Abu-Fares, Paul Bronzlik, Friedrich Götz, Hans Worthmann, Ramona Schuppner, Gerrit M. Grosse, Karin Weissenborn
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 15 (2022)
Background: In acute ischemic stroke, timely treatment is of utmost relevance. Identification of delaying factors and knowledge about challenges concerning hospital structures are crucial for continuous improvement of process times in stroke care. Ob
Externí odkaz:
https://doaj.org/article/7d2b6a097ecb45338933cb460a5d3bfc
Autor:
Karin Weissenborn, Sam Gruber, Gerrit M. Grosse, Maria Gabriel, Ramona Schuppner, Hans Worthmann, Omar Abu-Fares, Friedrich Götz
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background and Purpose: Pre- and intra-hospital workflow in mechanical recanalization of large cervicocephalic arteries in patients with acute ischemic stroke still needs optimization. In this study, we analyze workflow and outcome in our routine car
Externí odkaz:
https://doaj.org/article/dc8bb10e72dd44e38d1a62db56300506
Autor:
Lars Hendrik Müschen, Alma Osmanovic, Camilla Binz, Konstantin F. Jendretzky, Gresa Ranxha, Paul Bronzlik, Omar Abu-Fares, Flavia Wiehler, Nora Möhn, Martin W. Hümmert, Stefan Gingele, Friedrich Götz, Martin Stangel, Thomas Skripuletz, Olivia Schreiber-Katz, Susanne Petri
Publikováno v:
Brain Sciences, Vol 11, Iss 3, p 296 (2021)
Approval of nusinersen, an intrathecally administered antisense oligonucleotide, for the treatment of 5q-spinal muscular atrophy (SMA) marked the beginning of a new therapeutic era in neurological diseases. Changes in routine cerebrospinal fluid (CSF
Externí odkaz:
https://doaj.org/article/728a945366eb4726a2918792f555c347
Autor:
Gerrit M. Grosse, Nicole Blume, Omar Abu-Fares, Friedrich Götz, Johanna Ernst, Andrei Leotescu, Maria M. Gabriel, Till van Gemmeren, Hans Worthmann, Ralf Lichtinghagen, Rabea Imker, Christine S. Falk, Karin Weissenborn, Ramona Schuppner, Nicole de Buhr
Publikováno v:
Stroke. 53:1235-1244
Background: Cell-free DNA (cfDNA) and endogenous deoxyribonuclease activity are opposing mediators and might influence the inflammatory response following acute ischemic stroke. In this cohort study, we investigated the relation between these markers
Autor:
Gerrit M. Grosse, Maria M. Gabriel, Karin Weissenborn, Friedrich Götz, Mark P. Kühnel, Nicole Blume, Johanna Ernst, Omar Abu-Fares, Ramona Schuppner, Hans Worthmann, Christine S. Falk, Danny Jonigk, Andrei Leotescu, Christopher Werlein
Publikováno v:
Thrombosis and Haemostasis. 122:623-632
Mechanical thrombectomy (MT) is a highly efficient treatment in patients with acute ischemic stroke due to large vessel occlusion (LVO). However, in a relevant proportion of LVO, no sufficient recanalization can be achieved. The composition of cerebr
Autor:
Gerrit M. Grosse, Karin Weissenborn, Friedrich Götz, Sam Gruber, Omar Abu-Fares, Ramona Schuppner, Hans Worthmann, Maria M. Gabriel
Publikováno v:
Frontiers in Neurology
Frontiers in Neurology, Vol 12 (2021)
Frontiers in Neurology, Vol 12 (2021)
Background and Purpose: Pre- and intra-hospital workflow in mechanical recanalization of large cervicocephalic arteries in patients with acute ischemic stroke still needs optimization. In this study, we analyze workflow and outcome in our routine car
Publikováno v:
Nervenheilkunde. 38:409-416
ZUSAMMENFASSUNGFür die 5q-assoziierte spinale Muskelatrophie (SMA) ist mit dem Antisense-Oligonukleotid Nusinersen seit Juni 2017 in Europa die erste kausale Therapie verfügbar. Die Zulassung beruht auf Phase-III-Studien bei Kindern und umfasst alt
Publikováno v:
Dtsch Arztebl Int
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::783511c1c1bc1508b42687d0a8a16f40
https://europepmc.org/articles/PMC8220026/
https://europepmc.org/articles/PMC8220026/
Autor:
Susanne Petri, Olivia Schreiber-Katz, Stefan Gingele, Martin W. Hümmert, Nora Möhn, Lars H. Müschen, Gresa Ranxha, Friedrich Götz, Flavia Wiehler, Camilla Binz, Martin Stangel, Thomas Skripuletz, Omar Abu-Fares, Konstantin Fritz Jendretzky, Paul Bronzlik, Alma Osmanovic
Publikováno v:
Brain Sciences
Brain Sciences, Vol 11, Iss 296, p 296 (2021)
Volume 11
Issue 3
Brain Sciences, Vol 11, Iss 296, p 296 (2021)
Volume 11
Issue 3
Approval of nusinersen, an intrathecally administered antisense oligonucleotide, for the treatment of 5q-spinal muscular atrophy (SMA) marked the beginning of a new therapeutic era in neurological diseases. Changes in routine cerebrospinal fluid (CSF